References

• 1995The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories14,509 cited
• 2005The short‐form version of the Depression Anxiety Stress Scales (DASS‐21): Construct validity and normative data in a large non‐clinical sample5,796 cited
• 2018Psychedelics Promote Structural and Functional Neural Plasticity1,201 cited
• 2012The Depression Anxiety Stress Scales—21 (DASS‐21): Further Examination of Dimensions, Scale Reliability, and Correlates1,070 cited
• 2007Depression Anxiety and Stress Scales (DASS-21): Psychometric analysis across four racial groups708 cited
• 2019Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels513 cited
• 2002The pharmacology of psilocybin463 cited
• 2015Differential changes in self-reported aspects of interoceptive awareness through 3 months of contemplative training349 cited
• 2014Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers323 cited
• 2012Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors298 cited
• 2019A systematic study of microdosing psychedelics235 cited
• 2021Self-blinding citizen science to explore psychedelic microdosing192 cited
• 2007The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval